Medrx Reports Massive Exercise of Warrant Shares

TOKYO, Jul 17 (Pulse News Wire) – Medrx CO.,LTD. (4586.T) reported a significant exercise of warrant shares during July 16-17, 2026.

According to the disclosure, 1,634,400 shares were delivered based on the exercise of warrants issued to Growth Capital Corporation on June 5, 2026. A total of 1,644,965 warrant shares have been exercised since the last disclosure, representing approximately 27.3% of the total outstanding warrants.

As of the latest report, there remain 4,355,035 unexercised warrant shares out of the initial issuance of 15,800,000 warrants. Prior to the recent exercises, 4,355,035 warrant shares were unexercised, indicating a consistent trend in warrant utilization.

For more detailed information on the issuance of these warrants, interested parties may refer to the May 20, 2026, press release titled “Issuance of Third Party Allocation Type 35th Series Warrants (Exercise Price Adjustment Clause).”.